Nuvectis Pharma, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Several Soleus-affiliated entities and Guy Levy have jointly filed a Schedule 13G, reporting beneficial ownership of Nuvectis Pharma, Inc. common stock.